235 related articles for article (PubMed ID: 31792737)
1. The Role of Melatonin in Colorectal Cancer.
Iravani S; Eslami P; Dooghaie Moghadam A; Moazzami B; Mehrvar A; Hashemi MR; Mansour-Ghanaei F; Mansour-Ghanaei A; Majidzadeh-A K
J Gastrointest Cancer; 2020 Sep; 51(3):748-753. PubMed ID: 31792737
[TBL] [Abstract][Full Text] [Related]
2. Melatonin: An important anticancer agent in colorectal cancer.
Mirza-Aghazadeh-Attari M; Mohammadzadeh A; Mostavafi S; Mihanfar A; Ghazizadeh S; Sadighparvar S; Gholamzadeh S; Majidinia M; Yousefi B
J Cell Physiol; 2020 Feb; 235(2):804-817. PubMed ID: 31276205
[TBL] [Abstract][Full Text] [Related]
3. Melatonin as a potential inhibitor of colorectal cancer: Molecular mechanisms.
Shafabakhsh R; Reiter RJ; Davoodabadi A; Asemi Z
J Cell Biochem; 2019 Aug; 120(8):12216-12223. PubMed ID: 31087705
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic Targeting of the Colorectal Tumor Stroma.
Fridman WH; Miller I; Sautès-Fridman C; Byrne AT
Gastroenterology; 2020 Jan; 158(2):303-321. PubMed ID: 31622621
[TBL] [Abstract][Full Text] [Related]
5. Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits.
Hao J; Fan W; Li Y; Tang R; Tian C; Yang Q; Zhu T; Diao C; Hu S; Chen M; Guo P; Long Q; Zhang C; Qin G; Yu W; Chen M; Li L; Qin L; Wang J; Zhang X; Ren Y; Zhou P; Zou L; Jiang K; Guo W; Deng W
J Exp Clin Cancer Res; 2019 Feb; 38(1):48. PubMed ID: 30717768
[TBL] [Abstract][Full Text] [Related]
6. Biochemotherapy with standard chemotherapies plus the pineal hormone melatonin in the treatment of advanced solid neoplasms.
Lissoni P
Pathol Biol (Paris); 2007; 55(3-4):201-4. PubMed ID: 17446010
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms Underlying Tumor Suppressive Properties of Melatonin.
Bondy SC; Campbell A
Int J Mol Sci; 2018 Jul; 19(8):. PubMed ID: 30060531
[TBL] [Abstract][Full Text] [Related]
8. The potential therapeutic actions of melatonin in colorectal cancer.
Chok KC; Ng CH; Koh RY; Ng KY; Chye SM
Horm Mol Biol Clin Investig; 2019 May; 39(1):. PubMed ID: 31141480
[TBL] [Abstract][Full Text] [Related]
9. Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review.
Mortezaee K; Najafi M; Farhood B; Ahmadi A; Potes Y; Shabeeb D; Musa AE
Life Sci; 2019 Jul; 228():228-241. PubMed ID: 31077716
[TBL] [Abstract][Full Text] [Related]
10. Impressive Suppression of Colon Cancer Growth by Triple Combination SN38/EF24/Melatonin: "Oncogenic"
Bakalova R; Zhelev Z; Shibata S; Nikolova B; Aoki I; Higashi T
Anticancer Res; 2017 Oct; 37(10):5449-5458. PubMed ID: 28982855
[TBL] [Abstract][Full Text] [Related]
11. The emergence of melatonin in oncology: Focus on colorectal cancer.
Gil-Martín E; Egea J; Reiter RJ; Romero A
Med Res Rev; 2019 Nov; 39(6):2239-2285. PubMed ID: 30950095
[TBL] [Abstract][Full Text] [Related]
12. A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates.
Barni S; Lissoni P; Cazzaniga M; Ardizzoia A; Meregalli S; Fossati V; Fumagalli L; Brivio F; Tancini G
Oncology; 1995; 52(3):243-5. PubMed ID: 7715908
[TBL] [Abstract][Full Text] [Related]
13. Melatonin May Increase Anticancer Potential of Pleiotropic Drugs.
Bojková B; Kubatka P; Qaradakhi T; Zulli A; Kajo K
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30563247
[TBL] [Abstract][Full Text] [Related]
14. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
[TBL] [Abstract][Full Text] [Related]
15. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
[TBL] [Abstract][Full Text] [Related]
16. Molecularly targeted therapy: toxicity and quality of life considerations in advanced colorectal cancer.
Ribecco AS; Pino MS; Cipriani G; Marinozzi C; Fioretto L
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1181-91. PubMed ID: 24134420
[TBL] [Abstract][Full Text] [Related]
17. Melatonin: A Potential Antineoplastic Agent in Breast Cancer.
Samanta S
J Environ Pathol Toxicol Oncol; 2022; 41(4):55-84. PubMed ID: 36374962
[TBL] [Abstract][Full Text] [Related]
18. Does the use of melatonin overcome drug resistance in cancer chemotherapy?
Asghari MH; Ghobadi E; Moloudizargari M; Fallah M; Abdollahi M
Life Sci; 2018 Mar; 196():143-155. PubMed ID: 29374563
[TBL] [Abstract][Full Text] [Related]
19. Melatonin Promotes Apoptosis of Oxaliplatin-resistant Colorectal Cancer Cells Through Inhibition of Cellular Prion Protein.
Lee JH; Yoon YM; Han YS; Yun CW; Lee SH
Anticancer Res; 2018 Apr; 38(4):1993-2000. PubMed ID: 29599315
[TBL] [Abstract][Full Text] [Related]
20. Melatonin Sensitizes Human Colorectal Cancer Cells to γ-ray Ionizing Radiation In Vitro and In Vivo.
Wang Q; Sun Z; Du L; Xu C; Wang Y; Yang B; He N; Wang J; Ji K; Liu Y; Liu Q
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
